Sage Therapeutics Inc
SAGE
Market Cap$572.99M
Close$
$-6.59
172.3% downside
Current Fair Value
172.3% downsideOvervalued by 172.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $572.99 Million |
|---|---|
| Enterprise Value | $539.63 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-6.59 |
| Beta | 0.18 |
| Outstanding Shares | 61,857,573 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.6 |
|---|---|
| PEG | 3.74 |
| Price to Sales | - |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | 11.38 |
| Enterprise Value to EBIT | -1.5 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sage Therapeutics Inc
CEO: Jeffrey Jonas